Abstract
Of 139 node-positive breast cancer patients treated with adjuvant chemotherapy, the pre-treatment levels of glutathione S-transferase (GST) classes alpha, mu and pi, were determined by immuno-quantification on Western blots in cytosols of the primary tumours. Their expression was studied with respect to cytosolic oestrogen-receptor, progesterone-receptor and cathepsin D levels, and to the length of disease-free survival. GST class pi was negatively correlated with oestrogen receptor and progesterone receptor, and positively correlated with cathepsin D. There was no correlation between GST isoenzymes and the length of disease-free survival. These data suggest that glutathione S-transferases are not useful as markers to predict the response to adjuvant chemotherapy in human breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peters, W., Roelofs, H., van Putten, W. et al. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 68, 86–92 (1993). https://doi.org/10.1038/bjc.1993.291
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.291
This article is cited by
-
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue
Breast Cancer Research and Treatment (2008)
-
Association of GSTP1 CpG Islands Hypermethylation with Poor Prognosis in Human Breast Cancers
Breast Cancer Research and Treatment (2006)
-
GlutathioneS-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study
Journal of Cancer Research and Clinical Oncology (1996)
-
Human cell lines as models for multidrug resistance in solid tumours
Cytotechnology (1993)